Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
OTHER

16S rRNA amplicon sequencing and untargeted metabolomics

"16S rRNA sequencing is a method for large-scale identification of community composition, expression abundance, and phylogenetic analysis by polymerase chain reaction (PCR) amplification of specific variable regions of 16S rRNA, combined with high-throughput sequencing and bioinformatics analysis. It also enables large-scale identification of the entire flora in a given habitat to study microbial diversity.~Untargeted metabolomics refers to the use of Liquid Chromatograph Mass Spectrometer (LC-MS), Gas Chromatograph Mass Spectrometer (GC-MS), and nuclear magnetic resonance (NMR) technology. The dynamic changes of small molecular metabolites in cells, tissues, organs or organisms before and after stimulation or disturbance were detected without bias. The differential metabolites were screened by bioinformatics analysis, and the pathway analysis of differential metabolites was performed to reveal the physiological mechanism of their changes."

Trial Locations (1)

250063

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT06147154 - Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients | Biotech Hunter | Biotech Hunter